Cytokinetics (CYTK)
14.45
+0.00 +0.00%
NASDAQ
Jun 23, 20:00
Delayed 2m
USD
View All Key Stats
CYTK Key Stats
| Income Statement | |
| Revenue (TTM) | 102.14M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.03 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 3.041M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -622.9% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 649.20M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 5.920 |
| PE Ratio (TTM) | 480.00 |
| Price to Book Value | 6.806 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.3147 |
| Free Cash Flow (Quarterly) | -22.33M |
| Return on Equity (TTM) | 4.00% |
View All CYTK News
CYTK News
-
WireHeadlineTime (ET)
-
Yahoo06/23 18:05
-
Globe Newswire06/23 16:00
-
Yahoo06/15 08:12
-
Globe Newswire06/13 16:00
-
Yahoo06/12 13:58
-
Yahoo06/09 09:29
-
Yahoo06/02 08:40
-
SA Breaking News05/15 09:59
-
MT Newswires05/15 07:53
-
Globe Newswire05/15 07:30
View All Events
CYTK Events
| Date | Type | Description |
|---|---|---|
| 05/18/2017 | Misc | Cytokinetics Inc Annual General Meeting in 2017 |
| 04/27/2017 16:00 EDT | Misc | Cytokinetics Inc First Quarter Earnings Conference Call in 2017 |
| 04/27/2017 | Earnings | Cytokinetics Inc First Quarter Earnings in 2017 Release |
| 02/16/2017 16:30 EST | Misc | Cytokinetics Inc Fourth Quarter Earnings Conference Call in 2016 |
| 02/16/2017 | Earnings | Cytokinetics Inc Fourth Quarter Earnings in 2016 Release |
| 10/27/2016 16:00 EDT | Misc | Cytokinetics Inc Third Quarter Earnings Conference Call in 2016 |
| 10/27/2016 | Earnings | Cytokinetics Inc Third Quarter Earnings in 2016 Release |
| 07/28/2016 16:30 EDT | Misc | Cytokinetics Inc Second Quarter Earnings Conference Call in 2016 |
| 07/28/2016 | Earnings | Cytokinetics Inc Second Quarter Earnings in 2016 Release |
CYTK Fundamentals
Income Statement View Statement
CYTK Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
CYTK One Page Reports
- One Page Report Download
CYTK Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 14.45 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.cytokinetics.com
- Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=142156&p=irol-IRHome
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: Apr. 27, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
CYTK Comparables
EditCYTK Excel Add-In Codes
- Name: =YCI("CYTK","name")
- Description: =YCI("CYTK","description")
- Sector: =YCI("CYTK","sector")
- Industry: =YCI("CYTK","industry")
- Est. Current Fiscal Year End: =YCI("CYTK","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other CYTK Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CYTK Tweets Stocktwits
Advertisement
